Related Experiment Video
Updated: Aug 1, 2025

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
Published on: November 9, 2017
Immune-Mediated Neuropathies: Pathophysiology and Management.
Abhishek Shastri1, Ahmad Al Aiyan2, Uday Kishore2
1Central and North West London NHS Foundation Trust, London NW1 3AX, UK.
Immune system dysfunction can damage the peripheral nervous system through inflammation and demyelination. Understanding immunological mechanisms, antibodies, and electrophysiology aids in diagnosing and treating various dysimmune neuropathies.
Area of Science:
- Neuroimmunology
- Peripheral Nervous System Disorders
Background:
- Immune system dysfunction can lead to peripheral nervous system damage, including demyelination and axonal degeneration.
- Mechanisms involve macrophage infiltration, inflammation, and Schwann cell proliferation, with diverse etiologies sometimes triggered by infection.
Purpose of the Study:
- To review the immunological and pathophysiological mechanisms of dysimmune neuropathies.
- To discuss electrophysiological characteristics, laboratory features, and treatment options for these disorders.
Main Methods:
- Review of existing literature on immune-mediated neuropathies.
- Discussion of animal models for inflammatory polyradiculoneuropathies.
- Analysis of antibody detection and electrophysiological findings.
Main Results:
- Specific antibodies (anti-glycoconjugate, paraneoplastic) aid in classification and diagnosis, indicating molecular mimicry or immune reactions to tumors.
- Electrophysiological findings like conduction blocks help differentiate subtypes, such as multifocal motor neuropathy with conduction block and Lewis-Sumner syndrome.
Conclusions:
- Dysimmune neuropathies encompass a range of disorders with distinct immunological and pathophysiological underpinnings.
- Accurate diagnosis and classification rely on integrating clinical, immunological, and electrophysiological data for effective treatment and prognosis.
More Related Videos
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
08:47Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
Published on: May 8, 2016
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Myocarditis IV: Nursing Management
Myocarditis III: Medical Management
Peripheral Artery Disease IV: Nursing Management